期刊文献+

采用抗体库技术筛选抑制肺癌的功能性抗体 被引量:3

Identification of Functional Antibodies of Lung Cancer by Screening of Functional Antibody Library
下载PDF
导出
摘要 目的研制抑制肺癌细胞功能性单抗,为治疗肺癌提供靶向治疗剂,并为分离获得肺癌相关的分子靶标打下基础。方法从新鲜人肺癌组织分离肿瘤细胞免疫Balb/c小鼠,免疫小鼠脾细胞与SP2/0细胞融合后接种于甲基纤维素,制备大容量功能性抗体库。采用活细胞荧光、ELISA、免疫组化、肿瘤增殖、侵袭、黏附、动物体内治疗实验等方法筛选鉴定抑制肿瘤细胞的功能性单抗。结果本次融合共获得了1573株杂交瘤克隆,在能与肺癌细胞膜反应的314株克隆中,154株与正常肺组织不反应或低反应。功能性筛选发现41株单抗显著地抑制肺癌细胞增殖,24株能抑制肺癌细胞对Matrigel的侵袭,15株能抑制肺癌细胞与CollagenI的黏附,进一步实验验证了2株单抗能在体内抑制肺癌移植瘤的生长。结论采用大容量功能性抗体库技术成功获得了多株具有抑制肺癌细胞恶性生物学行为的功能性单抗,其中2株可能具有靶向治疗肺癌的应用潜力。 Objective Monoclonal antibodies which inhibit lung cancer may be candidate drugs for the antimalignancy therapy. Methods Malignant cells were separated form lung carcinoma tissues to immunize Balb/c mouse. The spleen cells of the immunized mouse were fused with SP2/I) cells and culture on the methyl cellulose. Antibodies of each clone were screened by immunofluorescence, immunohistochemistry, ELISA, cell proliferation assay, tumor cell invasion assay and adhesion assay. Functional antibodies were also studied by tumor treatment experiments in viva. Results One thousand five hundred and seventy-three monoclonal antibody clones were obtained by the fuse of spleen cells with SP2/0 cells. Fortyone clones could significantly suppress the lung cancer cell proliferation, 24 monoclonal antibody could inhibit tumor cell invasion in Matrigel, and 15 monoclonal antibody could decrease the adherence between lung cancer cells and Collagen I. In vivo assay further demonstrated that two of these functional antibodies could significantly inhibit lung tumor growth in mice. Conclusion By using functional antibody library, we successfully obtained functional monoclonal antibodies which suppressed the lung cancer cells in vitro and in vivo. These antibodies may be applied in anti-tumor therapy of lung carcinoma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2007年第6期395-398,I0001,共5页 Cancer Research on Prevention and Treatment
基金 国家自然科学基金面上资助项目(30570818) 国家重点基础研究发展规划973项目(2002CB513106)
关键词 肺癌 抗体库 功能性单抗 靶向治疗 Lung cancer Antibody library Functional antibody Tumor targeting therapy
  • 相关文献

参考文献12

  • 1Pirozynski M.100 years of lung cancer[J].Respir Med,2006,100(12):2073-2084.
  • 2Molina JR,Adjei AA,Jett JR.Advances in chemotherapy of non-small cell lung cancer[J].Chest,2006,130(4):1211-1219.
  • 3Solly K,Wang X,Xu X,et al.Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays[J].Assay Drug Dev Technol,2004,2(4):363-372.
  • 4Kurian AW,Thompson RN,Gaw AF,et al.A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer[J].J Clin Oncol,2007,25(6):634-641.
  • 5Collins-Burow B,Santos ES.Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma[J].Expert Rev Anticancer Ther,2007,7(3):257-273.
  • 6Aziz Z,Iqbal J,Akram M,et al.Treatment of chronic myeloid leukemia in the imatinib era:perspective from a developing country[J].Cancer,2007,109 (6):1138-1145.
  • 7Fernando NH,Hurwitz HI.Targeted therapy of colorectal cancer:clinical experience with bevacizumab[J].Oncologist,2004,9(Suppl 1):11-18.
  • 8Eustace BK,Sakurai T,Stewart JK,et al.Functional proteomic screens reveal an essential extracellular role for hsp90α in cancer cell invasiveness[J].Nature Cell Biology,2004,6(6):507-514.
  • 9Zhou YJ,Wang SQ,Zhang J,et al.A novel method to isolate and map endothelial membrane proteins from pulmonary vasculature[J].Am J Physiol Cell Physiol,2005,288(4):C950-C956.
  • 10Zhang Y,Ran Y,Yu L,et al.Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth[J].Anticancer Res,2006,26(4B):2963-2970.

同被引文献18

  • 1Wan-Yee Lau,Eric C. H. Lai.Hepatocellular carcinoma: current management and recent advances[J].Hepatobiliary & Pancreatic Diseases International,2008,7(3):237-257. 被引量:102
  • 2遇珑,潘健,周转,冉宇靓,胡海,娄晋宁,杨治华.抑制食管癌与肺血管内皮黏附的功能性抗体的制备[J].中国肿瘤生物治疗杂志,2006,13(5):332-337. 被引量:4
  • 3Soria JC, Shepherd FA, Douillard JY, et al. Efficacy of everolimus ( RADO01 ) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors [J]. Ann Oncol, 2009, 20(10) : 1674-1681.
  • 4Oh P, Li Y, Yu J, et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy [J]. Nature, 2004, 429(6992): 629-635.
  • 5Eustace BK, Sakurai T, Stewart JK, et al. Functional proteomic screens reveal an essential extracellular role for HSP90 alpha in cancer cell invasiveness [ J ]. Nat Cell Biol, 2004, 6 ( 6 ) : 507- 514.
  • 6Esposito L,Conti D,Ailavajhala R. Lung cancer:are we up to the challenge[J].Current Genomics,2010,(07):513-518.
  • 7Cagle PT,Chirieac LR. Advances in treatment of lung cancer with targeted therapy[J].Archives of Pathology and Laboratory Medicine,2012,(05):504-509.
  • 8Robinet G,Szczesna A. Randomized phase Ⅱ study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer[J].Annals of Oncology,2008,(02):362-369.doi:10.1093/annonc/mdm474.
  • 9赵西路,陈立钊,冉宇靓,胡海,孙立新,遇珑,杨治华.抑制胃癌增殖功能性单抗的制备、筛选及鉴定[J].中国卫生检验杂志,2008,18(6):1013-1015. 被引量:3
  • 10卢燕来,冉宇靓,遇珑,赵西路,刘军,胡海,杨治华.功能差异细胞模型筛选抗肺癌功能性单克隆抗体及其抗原[J].中国肿瘤生物治疗杂志,2008,15(6):501-507. 被引量:6

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部